Carol Gail Ashe
CIK: 0001761748
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Elicio Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Aug 31, 2026ELTX
Elicio Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
21.8K shares- - May 19, 2025ELTX
Elicio Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
7.9K shares- - Nov 21, 2024ELTX
Elicio Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
4.1K shares-
1-3 of 3 transactions
About Ashe Carol Gail
Ashe Carol Gail (SEC CIK 0001761748) files insider reports with the SEC as Director of Elicio Therapeutics, Inc. (ELTX).
Signal8 holds 3 ownership filings by Ashe Carol Gail, all Form 4s, filed between Nov 25, 2024 and Sep 2, 2026. Those filings report 3 transactions, from Nov 21, 2024 to Aug 31, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ashe Carol Gail's filings is in BOSTON, MA.
Recent filings by Ashe Carol Gail
Other insiders filing for Elicio Therapeutics, Inc. (ELTX)
- ADAMS JULIAN, Director
- Chudnovsky Yekaterina, Director
- Nissenson Allen, Director
- RUFFOLO ROBERT R, Director
- WILSON KAREN J, Director
- Venkatesan Jay, Director